Earth Science Tech Inc.’s (ETST) Five-Year Plan: Expand Manufacturing, Marketing of Proprietary Products to Diverse Channels

• ETST outlined a multiple-year goal of growing a market for its pure, natural extracted products in the CBD space
• The company creates proprietary CBD products that are unique to the nutraceuticals industry
• Its cutting-edge technology, including its super-critical extraction process, is designed to create pure and natural hemp oil

Earth Science Tech Inc. (OTCQB: ETST) outlined a five-year plan in its July 10-K annual report filed with the SEC. The report details a strategy of creating ETST’s proprietary line of CBD hemp extracts through a gentle and natural process that utilizes a super-critical extraction process using CO2 compression, isolation and micron filtration (http://ibn.fm/H330b).

The result is high-grade, CBD-rich hemp oil and other CBD products that have additional natural molecules. ETST’s highly technical extraction process creates pure, easily digested, rich CBD hemp oil that’s unique to the nutraceuticals industry. ETST plans to scale-up its processing capability to accommodate new products in its pipeline, per the report, and it aims to make its innovative hemp products available worldwide.

The report also explained that hemp-based CBD is one of at least 80 cannabinoids found in hemp and is non-psychoactive.

ETST’s U.S.-based operation oversees its supply chain, including raw material processing, product development and manufacturing, and sales and marketing. ETST plans to continue expanding its line of supplements and proprietary CBD-rich hemp oil to broad and diverse channels, including online, pharmacies, clinics and in-store sales.

ETST is currently sourcing its CBD-rich hemp oil from high-quality industrial hemp plants grown in Oregon and Kentucky. Referencing its product’s cultivation, ETST maintains that its CBD-rich hemp oil is “sourced from the high quality industrial hemp plants grown by generational family farmers,” and that, throughout the process, the product is lab tested several times “from seed to shelf” for “cannabinoid panel content, terpenoids, pesticides, residual solvents, mycotoxins and micros.” This attention to detail in production quality is a valuable hallmark of ETST’s success, differentiating it from its competitors.

“We believe that our formulations will set us apart from competing products for promoting health,” the company stated in the SEC filing. “We have formulated and produced our initial CBD products, intended for subject to performance treating various symptoms of diseases and ailments or for overall health. The company plans to expand manufacturing and marketing of these CBD products with expansion of products over the next five years.”

ETST is a biotech company focused on the nutraceutical and pharmaceutical fields. It performs R&D on cannabis and industrial hemp, markets a line of cannabis products, and maintains a portfolio of diverse subsidiaries.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php